Skip to main content
SEARCH

How will Brexit affect the Pharma industry?

The UK’s pharmaceutical industry is one of the most important sectors in the country. Closely tied to the international market, and employing up to 70,000 national and international scientists, the pharma industry generates over 10% of the country’s GDP and continues to develop and market drugs that have saved lives around the world.

Any changes to this market due to Brexit are therefore likely to have far-reaching consequences within the industry. From research to pricing, every stage of drug development will be affected as legislation and market demand change and the country faces an uncertain future. Given the importance of the UK as a centre for pharmaceutical excellence, it also seems likely that the impact of Brexit will be felt around the world too.

What changes are on the horizon, and which approaches are pharmaceutical companies likely to take to tackle this over the coming year?

One thing that should be considered first is the type of deal that the UK will strike with the European Union come the 29th March 2019, the date that the country officially leaves. Though of course it would be in the pharmaceutical industry’s best interests to maintain close links to the EU, and to the European Common Market, this may not happen. Depending on what happens, the UK could remain as an EEA member, which would ensure the greatest market stability, and the greatest access to the Single Market. Furthermore, the pharmaceutical industry would continue to operate under the same trading rules and regulations as the rest of the EU. However, a Free Trade Agreement, or WTO deal, could also be signed, effectively cutting the UK market off from EU resources, funding and the single market. 

However, what seems clear is that the UK pharmaceutical industry will face a great deal of uncertainty around R&D funding. The UK is currently a part of many of the EU’s Research and Innovation Programmes, among which is Horizon2020, the largest life sciences public-private partnership in the world, which contains over fifty projects that fund research around the UK. When the UK leaves Horizon2020, it’s been estimated that £8.5bn of funding and investment will be threatened; as a result, many UK-based multinationals are considering transferring key research projects to the EU to ensure that they can still take part in international research programmes. In the UK, pharma and life science companies would have to compete for a shrinking pool of funding. 

Leaving the EU also poses a range of problems that must be addressed when it comes to attracting new talent, and maintaining trade links. In the past, American and Asian markets have invested heavily in the UK, setting up companies there in order to gain a foothold in the European market. After Brexit, if the UK does not secure a Switzerland-style deal to the EEA, many companies will look to the continent to secure continued access to unfettered trading; countries like Germany, the Netherlands and Belgium all have a strong pharmaceutical heritage, trained, skilled scientists and a highly English-literate population. 

A similar problem is also on the horizon when it comes to the labour force: of the 73,000 employed in the Biotech and pharma sectors in the UK, 7% are EU nationals, and many international companies based in the UK will employ a range of international, skilled scientists in everything from research to patents. Though it’s not yet certain what will happen, it seems likely that to avoid lengthy visa processes and costs, that many will relocate to the EU, leaving large numbers of vacancies in the UK for skilled positions across the industry. 

However, Brexit also brings with it opportunities for the UK to make the most of its current status as a world leader in clinical research and pharma. The medical resource centre Merck, Sharp and Dohme recently published plans for a new life sciences discovery research facility in the UK, supporting 150 research-based roles, whilst a new partnership was also announced between diagnostics company Qiagen, and Health Innovation Manchester, which aims to develop a genomics and diagnostics campus in the city, providing another 800 jobs. Furthermore, the government recently proposed new plans to ensure that products authorised for sale in the EU, like cars and medicines, could be sold after Brexit.

Alongside further forthcoming announcements of investment in Biotech and pharma sectors, it seems that some companies are still keen on making the most of Britain’s fundamental strengths: its excellent universities, world-class research facilities and London’s position as a global financial centre.

How should pharma companies deal with the uncertainty that accompanies Brexit? By taking the time to plan for uncertainty, and considering the main scenarios for the UK’s departure from the EU, taking into account labour, regulations and investment in order to better prepare for every eventuality. Though Brexit looks to be a major turning point in the history of the UK’s pharma and Life Sciences sector, it also offers new opportunities, new ways of doing business and opportunities to maintain the UK’s status as a leader in the industry. 

At IQVIA, we keep up to date with the latest news in the industry so we can continue matching the freshest talent with the best opportunities around the world. Find out more about life in the pharmaceutical industry here, or browse our jobs here.
 
Sources

https://www.pharmaceuticalonline.com/

http://www.bbc.co.uk/news/uk-politics-32810887 

http://www.bbc.co.uk/news/business-42213937 

https://ec.europa.eu/programmes/horizon2020/ 

http://www.greatplacetowork.co.uk/storage/documents/

https://pharmaphorum.com/views-and-analysis/beyond-brexit-uk-can-continue-attract-foreign-investment/ 

https://pharmaphorum.com/news/uk-pharma-welcomes-government-post-brexit-trade-paper/ 

 
List #1

IQVIA Related insights

tablet PC and medical equipments, medical technology concept
How to turn a medical science liaison job into a career

Teaser

Medical Affairs & Services

Content Type

Article

Published

04/07/2024

Summary

Becoming a Medical Science Liaison is a popular career choice for many Doctoral-level candidates seeking a meaningful role within the pharmaceutical industry where they can communicate scientifically

Teaser

We look at the possible medical science liaison career paths that could be available to you.

Read more
Tracey Smith

by

Tracey Smith

Tracey Smith

by

Tracey Smith

A person in a medical jacket holding a box of pills typing on a laptop
Clinical Pharmacist Interview Tips: Securing Your Next Opportunity

Teaser

Patient Centric Services (PCS)

Content Type

Article

Published

04/07/2024

Summary

The clinical pharmacy industry is booming. Since the pandemic, the general public has become more aware of how pharmacists play a vital role in healthcare. Naturally, the market for these roles is al

Teaser

IQVIA has compiled some top Clinical Pharmacist Interview Tips.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

Amir, clinical pharmacist at IQVIA
Clinical Pharmacist duties - a day in the life

Teaser

Patient Centric Services (PCS)

Content Type

Article

Published

01/07/2024

Summary

If you’ve been doing your research into your next clinical pharmacy-based career, you might find yourself thinking “What are the daily activities of a Clinical Pharmacist?”.  To answer that question

Teaser

We caught up with Amir Khosravi-Nik, Senior Clinical Pharmacist at IQVIA.

Read more
Catherine Scott

by

Catherine Scott

Catherine Scott

by

Catherine Scott

Kareem, clinical pharmacist at IQVIA interface
IQVIA Interface - Kareem’s Clinical Pharmacist career story

Teaser

Clinical Operations

Content Type

Article

Published

28/06/2024

Summary

Kareem Mohamed joined IQVIA Interface in 2023 as a Clinical Pharmacist after having previously worked as a Primary Care Network (PCN) Pharmacist.  Our Clinical Pharmacists play a huge part in any h

Teaser

Kareem Mohamed joined IQVIA Interface in 2023 as a Clinical Pharmacist.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

hands holding a red heart against a blue backdrop
5 ways you can celebrate World Well-being Week this year

Teaser

General

Content Type

Article

Published

29/05/2024

Summary

World Well-being Week 2024 is just around the corner. As an organisation with a passion for building a healthier world, our mission is not just confined to healthcare and medical sales, it also exten

Teaser

World Well-being Week 2024 is near, here are 5 ways you can celebrate.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

Tips on how to keep your work life and home life separate

Teaser

General

Content Type

Article

Published

30/04/2024

Summary

Whether you work remotely, with a hybrid model, or are a careerist who can’t help but mentally take your work home with you when you leave the office, it’s undeniable that the lines between work and

Teaser

Explore learnable skills, tricks, and techniques that can empower you in your lifestyle

Read more
man in white lab coat holding glasses and talking to a man and woman
Why should you work in medical sales?

Teaser

Medical Sales & Services

Content Type

Article

Published

19/03/2024

Summary

Are you wondering if medical sales is a good career? All over the world, the medical and pharmaceutical sectors are booming, and nowhere more so than in the UK. With a thriving ecosystem of research

Teaser

All over the world, the medical and pharmaceutical sectors are booming, and nowhere more so than in the UK.

Read more
Two women on an interview
Navigating Career Growth and Flexibility at IQVIA: a Q&A with Lucy

Teaser

General

Content Type

Article

Published

05/02/2024

Summary

Lucy Manning sits in our clinical trials team, but that’s not where her career started at IQVIA. It all began at the back end of 2022 when Lucy took on a fixed-term contract as a Project Support Coo

Teaser

Lucy took on a fixed-term contract as a Project Support Coordinator. . But that did not signal the end of her time working with us.

Read more
doctor and medical sales representative shake hands
The Ultimate A-Z of Becoming a Medical Sales Rep

Teaser

Sales

Content Type

Article

Published

02/02/2024

Summary

Does the idea of being a medical sales rep excite you? This crucial position lets you make connections with companies and practitioners in the medical field. It’s also a growing and dynamic industry.

Teaser

This crucial position lets you make connections with companies and practitioners in the medical field.

Read more
female phlebotomist taking a blood sample from a male
How to become a phlebotomist

Teaser

Patient Centric Services (PCS)

Content Type

Article

Published

04/01/2024

Summary

Are you ready to step into a career that's both rewarding and accessible? Becoming a phlebotomist could be your ticket into the thriving world of healthcare. It's not just about drawing blood; it's ab

Teaser

Ready to discover how you could take the leap into this exciting field?

Read more
Young sad female nurse, doctor, carer looking through window, wearing face mask gazing at sun
Marissa's inspiring journey as a nurse advisor at IQVIA

Teaser

Medical

Content Type

Article

Published

20/11/2023

Summary

In the tapestry of healthcare, where expertise meets innovation, individuals like Marissa, a Senior Nurse Advisor at IQVIA, play a pivotal role.  Marissa has not only learned from challenges but has e

Teaser

If you consider the path of a Nurse Advisor, Marissa's story is a testament to the opportunities and fulfilment that await at IQVIA.

Read more
Human resources officer (headhunter, personnel) looking for a key account manager.
How the best key account managers stand out from the rest

Teaser

Sales

Content Type

Article

Published

13/11/2023

Summary

A guide to excelling in Key Account Manager jobs in healthcare In the dynamic landscape of the healthcare industry, the role of a Key Account Manager (KAM) is pivotal. Experienced account managers con

Teaser

Read on to explore the essential aspects of excelling as a Key Account Manager.

Read more